-
Sponsored by Spoor & FisherDuncan Maguire and Paul Ramara of Spoor & Fisher explain how Tanzania’s recently introduced trademark recordation system now accepts ARIPO and foreign registrations, while national filings remain the strongest enforcement tool
-
Sponsored by Spoor & FisherNew patent and utility model procedures and updated fees form part of a legislative update to the Bangui Agreement that became effective in the new year, explains Craig Kahn of Spoor & Fisher Jersey
-
Sponsored by Adams & AdamsJames Davies and Vishen Pillay at Adams & Adams discuss IP protection strategies and ownership considerations for AI
-
Sponsored by Tilleke & GibbinsAlmost a year and a half after Myanmar enacted the Trademark Law 2019 on January 30 2019, the same question still lingers in the minds of many brand owners and attorneys: "When will the Trademark Law come into force?"
-
Sponsored by Hechanova GroupThe city of Manila was placed under Enhanced Community Quarantine (ECQ) on March 16 2020 and all government offices and private businesses except those providing essential services, were required to work from home or closed. Public transportation was suspended, and everyone was required to practise social distancing and wear face masks.
-
Sponsored by AnJie Law FirmOn January 15 2020, US President Donald Trump and Chinese vice-premier He Liu signed a trade agreement which President Trump has described as "the biggest deal anybody has ever seen." The deal promises to be the first phase of a larger new trade agreement between the US and China, announcing a significant de-escalation in the trade war between the two giants that has dragged along for more than one year. Of particular interest to those in the pharmaceutical industry will be Sections C and D of the first chapter of the trade agreement, which outline China's commitments to improve protection and enforcement of pharmaceutical-related patent rights, and in particular to creating an effective mechanism for early resolution of patent disputes between generic drug companies and pharmaceutical innovators, or a Chinese drug patent linkage system, as many may like to put it.
-
Sponsored by InventaVera Albino of Inventa explores how Portuguese wine producers use seemingly offensive names rooted in local history and folklore, and why trademark law often permits their registration
-
Sponsored by InspicosPeter Koefoed of Inspicos examines how the EPO Enlarged Board of Appeal referral G 1/26 could clarify the application of G 1/24 when assessing the allowability of amended patent claims under the EPC
-
Sponsored by MaiwaldAlexander Ortlieb, Moritz Kampmann, and Stephan Maidl of Maiwald highlight six EPO appeal decisions that map the absolute floor of what patent applications for AI inventions must disclose – and how spectacularly some applicants miss that mark
-
Sponsored by Licks AttorneysEduardo Hallak, Juliana Neves, and Sarah Lucas of Licks Attorneys examine Brazil's growing debate over patent term adjustment and the legislative proposals seeking to address examination delays
-
Sponsored by Becerril, Coca & BecerrilStephania Cardiel of Becerril, Coca & Becerril examines how recent reforms signal a regional move towards faster, more internationally aligned innovation systems
-
Sponsored by Daniel LawRoberta Arantes of Daniel Law looks at how the Brazilian legal landscape has responded to shifts in the concept of branding and its related levels of protection
-
Sponsored by Red PointsRed Points, in partnership with Managing IP hosted a webinar on April 7 at 9am PDT / 12pm EDT / 5pm BST to discuss best practices in uncovering and dismantling large-scale counterfeiters
-
Sponsored by OLIVARESMauricio Sámano of OLIVARES explores how the pandemic has changed IP processes for businesses in Mexico
-
Sponsored by OLIVARESSantiago Pedroza of OLIVARES looks at how the opposition procedure has undergone changes to protect right holders
-
Sponsored by Cabinet M OproiuRaluca Vasilescu of Cabinet M Oproiu considers how AI and pricing pressures could affect patent attorneys’ work in the near future
-
Sponsored by Bird & BirdNick Aries of Bird & Bird LLP examines how agentic AI could reshape brand discovery, trademark enforcement, and comparative advertising, and outlines key risks for brand owners
-
Sponsored by NLOTariq Shajahan and Willem Niesing of NLO analyse dredging-related patent filings in key jurisdictions and highlight contrasting Western and Asian approaches to innovation, from component-level engineering to system-wide methodologies and AI-driven optimisation